Camsirubicin Reduces Tumor Size in Advanced Soft Tissue Sarcoma
Treatment with camsirubicin led to a reduction in tumor size in patients with advanced soft tissue sarcoma.
Stay updated with breaking news from Accessed August. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Treatment with camsirubicin led to a reduction in tumor size in patients with advanced soft tissue sarcoma.
-- VAZKEPA® (icosapent ethyl) accepted by the Scottish Medicines Consortium (SMC) for restricted use within NHSScotland, as secondary prevention in adult statin-treated patients at high cardiovascular risk1 -- -- VAZKEPA® already commercially available in England, Wales, and Northern Ireland where NICE recommended its reimbursement and use across the National Health Service (NHS) in July 2022 -- -- Amarin now working with Health Boards across Scotland to secure formulary inclusion and ensure eli
New innovations are revolutionizing diagnostics and optimizing treatment outcomes, marking significant strides in the fight against digestive diseases.
Coverage from the July 25, 2023, Institute for Value-Based Medicine® session held in partnerhship with Emory's Winship Cancer Institute.
What does it mean to be creative?